OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production leverages Chinese hamster ovary (CHO) cells due to their robustness in expressing complex molecules. Optimizing these processes involves adjusting various parameters, including cell line development, media formulation, and bioreactor conditions. A key goal is to maximize antibody yield while minimizing production cos